As of August 2026 Karyopharm Therapeutics has a market cap of $48.04 Million USD. This makes Karyopharm Therapeutics the world's 10322th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Aug 9th, 2026 the market cap of Karyopharm Therapeutics was reported to be: